Angel News
Angel News

Back to Homepage

4th August 2021

Maven VCTs invest further £500k in GENinCode as company goes to IPO

Maven Capital Partners, one of the UK’s most active private equity houses, has invested a further £500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional £17 million gross and listing on AIM with a market capitalisation of £42.2 million.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage